Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate β-amyloid plaque deposition

Experimental Neurology

Volumn 154, Issue 2, 1998, Pages 573-582

  Tuszynski, Mark H ^a,b   Smith, David E ^a   Roberts, Jeffrey ^c   McKay, Heather ^c   Mufson, Elliott ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

13 amyloid; Aging; Alzheimer's disease; Gene therapy; Nerve growth factor; Neurotrophin; APP

Indexed keywords

AMYLOID BETA PROTEIN; NERVE GROWTH FACTOR;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; FOREBRAIN; FRONTAL CORTEX; GENE TARGETING; GENE TRANSFER; HIPPOCAMPUS; INSULA; MALE; NERVE CELL DEGENERATION; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RHESUS MONKEY; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 0032411163     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6956     Document Type: Article

References (53)

1. Alvarez A., Alarcon R., Opazo C., Campos E. O., Jose Munoz F., Calderon F. H., Dajas F., Gentry M. K., Doctor B. P., De Mello F. G., Inestrosa N. C. Stable complexes involving acetylcholinesterase and amyloid-b-peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18:1998;3213-3223.
2. Alvarez A., Opazo C., Alarcon R., Garrido J., Inestrosa N. C. Acetylcholinesterase promotes the aggregation of amyloid-b-peptide fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272:1997;348-361.
3. Bartus R., Dean R. L., Beer C., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
4. Chen K. S., Gage F. H. Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration. J. Neurosci. 15:1995;2819-2825.
5. Cosgaya J. M., Latasa M. J., Pascual A. Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells. J. Neurochem. 67:1996;98-104.
6. Coyle J. T., Price P. H., Delong M. R. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science. 219:1983;1184-1189.
7. Davis K. L., Thal L. J., Gamzu E. R., Davis C. S., Woolson R. F., Gracon S. I., Drachman D. A., Schneider L. S., Whitehouse P. J., Hoover T. M. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. New Engl. J. Med. 327:1992;1253-1259.
8. Fischer W., Wictorin K., Bjorklund A., Williams L. R., Varon S., Gage F. H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 329:1987;65-68.
9. Forloni G., Del Bo R., Angeretti N., Smiroldo S., Gabellini N., Vantini G. Nerve growth factor does not influence the expression of beta amyloid precursor protein mRNA in rat brain:In vivoin vitro. Brain Res. 620:1993;292-296.
10. Gomez-Isla T., Price J. L., McKeel D. W., Morris J. C., Growdon J. H., Hyman B. T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
11. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., Selkoe D. J. Amyloid b-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-327.
12. Hansen L. A., DeTeresa R., Davies P., Terry R. D. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology. 38:1988;48-54.
13. Hefti F. Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transection. J. Neurosci. 6:1986;2155-2162.
14. Hefti F., Weiner W. J. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20:1986;275-281.
15. Isaacson L. G., Saffran B. N., Crutcher K. A. Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels. Neurobiol. Aging. 11:1990;51-55.
16. Koliatsos V. E., Nauta H. J., Clatterbuck R. E., Holtzman D. M., Mobley W. C., Price D. L. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J. Neurosci. 10:1990;3801-3813.
17. Kordower J. H., Bartus R. T., Bothwell M., Schatteman G., Gash D. M. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): Distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277:1988;465-486.
18. Kordower J. H., Mufson E. J., Fox N., Martel L., Emerich D. F. Cellular delivery of NGF does not alter the expression of b-amyloid immunoreactivity in young or adult nonhuman primates. Exp. Neurol. 145:1997;586-591.
19. Kordower J. H., Winn S. R., Liu Y.-T., Mufson E. J., Sladek J. R., Hammang J. P., Baetge E. E., Emerich D. F. The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Nat. Acad. Sci. USA. 91:1994;10898-10902.
20. Kromer L. F. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 235:1987;214-216.
21. Lahiri D. K., Nall C. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Brain Res. Mol. Brain Res. 32:1995;233-240.
22. Markowska A. L., Koliatsos V. E., Breckler S. J., Price D. L., Olton D. S. Human nerve growth factor improves spatial memory in aged but not in young rats. J. Neurosci. 14:1994;4815-4824.
23. Martinez-Serrano A., Fischer W., Bjorklund A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron. 15:1995;473-484.
24. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer-disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
25. Menesini M. G., Chen J. S., Levi-Montalcini R. Sympathetic nerve fiber ingrowth in the central nervous system of neonatal rodent upon intracerebral nerve growth factor injections. Arch. Ital. Biol. 116:1978;53-84.
26. Mesulam M. M., Mufson E. J., Levey A. I., Wainer B. H. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214:1983;170-197.
27. Mobley W. C., Neve R. L., Prusiner S. B., McKinley M. P. Nerve growth factor induces gene expression for prion- and Alzheimer's beta-amyloid proteins. Proc. Natl. Acad. Sci. 85:1988;9811-9815.
28. Mufson E. J., Benzing W. C., Cole G. M., Wang H., Emerich D. F., Sladek J. R., Morrison J. H., Kordower J. H. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: Colocalization with amyloid plaques. Neurobiol. Aging. 15:1994;621-627.
29. Neve R. L., Valletta J. S., Li Y., Ventosa-Michelman M., Holtzman D. M., Mobley W. C. A comprehensive study of the spatiotemporal pattern of beta-amyloid precursor protein mRNA and protein in the rat brain: lack of modulation by exogenously applied nerve growth factor. Brain Res. Mol. Brain Res. 39:1996;185-197.
30. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1457-1459.
31. Rosenberg M. B., Friedmann T., Robertson R. C., Tuszynski M., Wolff J. A., Breakefield X. O., Gage F. H. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science. 242:1988;1575-1578.
32. Saffran B. N., Crutcher K. A. NGF-induced remodeling of mature uninjured axon collaterals. Brain Res. 525:1990;11-20.
33. Schumacher J. M., Short M. P., Hyman B. T., Breakefield X. O., Isacson O. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience. 45:1991;561-570.
34. Selkoe D. J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
35. Szabo J., Cowan W. M. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J. Comp. Neurol. 222:1984;265-300.
36. Tekirian T. L., Cole G. M., Russell M. J., Yang F., Wekstein D. R., Patel E., Snowdon D. A., Markesbery W. R., Geddes J. W. Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol. Aging. 17:1996;249-257.
37. Terry R. D., Katzman R., Bick K. L. Alzheimer Disease. 1994;Raven Press, New York.
38. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
39. Tuszynski M. H. Gene therapy for neurological disease. Ann. N.Y. Acad. Sci. 835:1998;1-11.
40. Tuszynski M. H., Buzsaki G., Gage F. H. NGF infusions combined with fetal hippocampal grafts enhance reconstruction of the lesioned septo-hippocampal projection. Neuroscience. 36:1990;33-44.
41. Tuszynski M. H., Gabriel K., Gage F. H., Suhr S., Meyer S., Rosetti A. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor and noradrenergic neurites after adult spinal cord injury. Exp. Neurol. 137:1996;157-173.
42. Tuszynski M. H., Gage F. H. Maintaining the neuronal phenotype after injury in the adult CNS. Mol. Neurobiol. 10:1995;151-167.
43. Tuszynski M. H., Roberts J., Senut M. C., U H.-S., Gage F. H. Gene therapy in the adult primate brain: Intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 3:1996;305-314.
44. Tuszynski M. H., Senut M. C., Roberts J., Ray J., Gage F. H. Fibroblasts genetically modified to produce NGF promote sprouting in the adult primate brain. Neurobiol. Dis. 1:1994;67-78.
45. Tuszynski M. H., Smith D., Gage F. H., Roberts J. Effects of NGF-secreting cells on cholinergic neurons in aged primates. Abstr. Soc. Neurosci. 22:1996;751.
46. Tuszynski M. H., U H.-S., Gage F. H. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 30:1991;625-636.
47. Tuszynski M. H., U H. S., Amaral D. G., Gage F. H. Nerve growth factor infusion in primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10:1990;3604-3614.
48. Ulrich J., Meier-Ruge W., Probst A., Meier E., Ipsen S. Senile plaques: Staining for acetylcholinesterase and A4 protein. A comparative study in the hippocampus and hippocampus. Acta Neuropathologica. 80:1990;624-628.
49. Walker L., Masters C., Beyreuther K., Price D. L. Amyloid in the brains of squirrel monkeys. Neurobiol. Aging. 8:1987;291-296.
50. Williams L. R. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp. Neurol. 113:1991;31-37.
51. Winkler J., Ramirez G. A., Kuhn H. G., Peterson D. A., Day-Lollini P. A., Stewart G. R., Tuszynski M. H., Gage F. H., Thal L. J. Reversible induction of Schwann cell hyperplasia and sprouting of sensory and sympathetic neuritesin vivo. Ann. Neurol. 40:1996;128-139.
52. Winters W. D., Kado R. T, Adey W. R. A Stereotaxic Brain Atlas for Macaca Nemestrina. 1969;Univ. California Press, Berkeley/Los Angeles.
53. Yuen E. C., Mobley W. C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40:1996;346-354.